Breaking AI & Tech News Analyzed

Court Hands Assistant Over Three‑Year Prison TermOn Wednesday, a Los Angeles judge sentenced Kenneth Iwamasa, 61, to three years and five months in federal prison for distributing ketamine that led to the death of Matthew Perry. The punishment aligns with prosecutors’ request and caps the criminal probe into the five individuals linked to Perry’s 2023 overdose.Assistant’s Direct Role in Administering KetamineFrom 2022 to 2023 Iwamasa served as Perry’s live‑in personal assistant. In the three days before the actor was found dead in a hot tub, Iwamasa injected him with six to eight ketamine shots per day, according to court documents. Prosecutors say Iwamasa paid former doctor Salvador Plasencia at least $55,000 to obtain the drug, and also coordinated with drug dealer Jasveen Sangha and addiction counselor Erik Fleming.Sentencing Numbers and Comparative PenaltiesKenneth Iwamasa: 3 years 5 months prisonJasveen Sangha (ketamine supplier): 15 years prisonErik Fleming (middleman): 2 years prisonSalvador Plasencia (doctor who supplied Iwamasa): 30 months prisonMark Chavez (doctor who sold ketamine to Perry): 8 months home detention + 3 years supervised releaseThe court’s decisions reflect the varying degrees of culpability, from direct administration to supply chain facilitation.Broader Implications for Celebrity Assistance and Drug RegulationThe case underscores the power imbalance between high‑profile clients and personal staff, a dynamic that can enable illicit drug access. Hollywood insiders noted that assistants often lack the authority to refuse dangerous requests, raising questions about workplace protections and the need for stricter oversight of non‑medical personnel handling controlled substances.Looking Ahead: Tighter Enforcement and Preventive MeasuresLegal experts predict increased federal scrutiny of unlicensed drug distribution networks, especially when they intersect with celebrity circles. Expect more rigorous background checks for personal assistants, heightened monitoring of ketamine prescriptions, and potential legislative proposals to criminalize the facilitation of controlled‑substance use without medical credentials.

The Sentencing of Matthew Perry's Former Assistant Kenneth Iwamasa, the former personal assistant to actor Matthew Perry, has been sentenced to 41 months in prison in connection with the television star's death from a fatal dose of the hallucinogenic drug ketamine. The Events Leading to Matthew Perry's Death Iwamasa had testified, as part of a plea agreement, that he injected Perry with ketamine at the actor's request on October 28, 2023, before leaving to run errands. He had no medical training. When Iwamasa returned, he found Perry's lifeless body floating in a hot tub at his home in Los Angeles's Pacific Palisades neighbourhood. Perry was 54 years old at the time. The Impact of Iwamasa's Actions Iwamasa allegedly gave Perry more than 25 shots of the drug in the days leading to his death, including three on the day he died. Court papers state that the Friends star had asked Iwamasa to 'shoot me up with a big one' in his final moments. An autopsy report found that Perry died from the 'acute effects of ketamine'. Prosecutors describe Iwamasa as Perry's 'enabler and supplier', continuing to give him injections despite troubling incidents. The Broader Investigation and Additional Convictions The sentencing of Iwamasa concludes the prosecution of five people alleged to have facilitated the actor's death by helping him access the drug without proper medical supervision. Erik Fleming, a certified drug counsellor, was sentenced to two years in prison for acting as a middleman to help supply Perry with controlled substances. Doctors Mark Chavez and Salvador Plasencia, who allegedly profited from Perry's addiction, were also convicted and sentenced in December. Jasveen Sangha, a British American woman who sold drugs to wealthy customers, was given a lengthy sentence of 15 years in prison. The Future Implications This case highlights the severe consequences of enabling and supplying controlled substances to individuals struggling with addiction. The sentencing serves as a warning to those who would seek to profit from or facilitate drug use.

The Sentencing of Erik Fleming A Los Angeles judge on Wednesday sentenced Erik Fleming, a licensed drug addiction counselor, to two years in prison for his role in the death of the Friends actor Matthew Perry. The Role in Matthew Perry's Death Fleming, 56, acted as a middleman by delivering the actor the doses of ketamine that killed him in October 2023. He had pleaded guilty in 2024 to a count of conspiracy to distribute ketamine, and a count of distribution resulting in death. The Investigation and Other Defendants Fleming was the fourth defendant sentenced in the case. Five have pleaded guilty in prosecutions over the actor’s 2023 death. The five people charged in the case include two doctors, Salvador Plasencia and Mark Chavez; the actor’s assistant Kenneth Iwamasa, who injected him with the drug before his death; Fleming, an acquaintance of Perry’s; and Jasveen Sangha, the convicted drug dealer. The Impact of the Case The case highlights the dangers of illicit ketamine use and the importance of addressing addiction and mental health issues. Matthew Perry, who had a long history of struggles with addiction and mental health, was found dead in the Jacuzzi at his Los Angeles home. The Future Outlook The sentencing of Erik Fleming and other defendants in the case serves as a reminder of the consequences of distributing and using illicit substances. It also underscores the need for continued efforts to address addiction and mental health issues in the entertainment industry and beyond.

The Quest for a "Disruptive" Cure in Silicon ValleyReturning to San Francisco in 2016, the author sought a solution to treatment-resistant depression within the city's petri dish of wellness innovation. Amidst a culture obsessed with disrupting every industry, the author attempted a series of cutting-edge interventions, believing the technological hub would offer a scalable solution to mental illness. However, the pursuit of high-tech fixes proved to be a cycle of disappointment, leading to a realization that human nature cannot be "hacked".The High-Tech Pipeline of Despair: Ketamine, TMS, and FMTThe author underwent a rigorous regimen of experimental therapies, ranging from clinical to underground:IV Ketamine Infusions: Receiving treatments at a Marin County clinic five times, despite the effects being minimal.Transcranial Magnetic Stimulation (TMS): Undergoing daily sessions for eight months in a sterile Union Square office, which ultimately failed to alter the author's mood.Fecal Microbiota Analysis: Participating in an elimination diet and stool analysis recommended by a WeWork nutritionist, which yielded no results.Underground Shamanic Ketamine: A final, ill-advised attempt involving a shaman that left the author feeling worse than before.The Promise vs. The Reality of Remission RatesWhile the author's personal journey yielded no relief, the broader data on these treatments presents a mixed picture. Research indicates that 52% of participants in ketamine studies achieved complete remission, and TMS has shown significant promise in clinical settings. However, the author highlights that 30% of people with major depressive disorder are treatment-resistant, meaning standard and experimental interventions alike may fail for a significant portion of the population.The Failure of "Disruption" in Mental HealthThe article critiques the Silicon Valley tendency to turn human suffering into a product. The sterile, high-tech environments of clinics and the commodification of wellness (biohacking, AI therapists) failed to address the root causes of the author's depression. The author contrasts this with the effectiveness of 12-step meetings and community support—frameworks developed nearly a century ago—suggesting that deep, unoptimized human connection is more effective than algorithmic or biochemical solutions.From Biohacking to Human ConnectionThe author's eventual recovery came not from a new technology, but from a return to fundamental human structures: sobriety, church basements, and communal living. The prediction for the future of mental health is a shift away from the "optimization" of the individual and toward the restoration of community and belonging.

New data from the National Survey on Drug Use and Health reveal that cocaine, once a hallmark of American party culture, is losing its grip: prevalence fell to 1.5% (about 4.3 million adults) in 2024, down from 5.9 million in 2017, and use among 18‑25‑year‑olds dropped from 2.1 million to 811 000.Key DevelopmentsOverall adult cocaine use: 1.5% in 2024 vs 6.7% in early 2000s.Gen Z (18‑25) consumption fell >60% between 2017 and 2024.Purity of seized cocaine rose to 88% in 2024, up from 54% in 2020.Overdose deaths involving cocaine climbed from 10,475 in 2016 to 22,174 in 2024.Alternative substances – ketamine, psychedelics, GHB, 3‑MMC and prescription stimulants – are reported as increasingly popular in club scenes.Data & Market Impact4.3 million adults reported cocaine use in the past year (2024).Supply surge from Colombia has driven purity up, potentially intensifying health risks.Mixed‑drug environment: law‑enforcement seizures now show higher rates of cocaine combined with fentanyl or other opioids, though true contamination remains low.Why This MattersThe decline reshapes several arenas:Public health: fewer users may reduce long‑term cardiovascular disease burden, but rising overdose deaths signal a dangerous shift toward polydrug use.Law‑enforcement: reduced demand could alter trafficking routes, while higher purity may incentivize dealers to diversify into more profitable synthetics.Pharmaceutical and wellness markets: growing preference for “controlled” substances like Adderall or therapeutic ketamine points to a broader wellness‑oriented drug culture.Policy: data may prompt a re‑evaluation of the “war on drugs” narrative and encourage harm‑reduction strategies targeting mixed‑drug use.Expert InsightAnalysts attribute the shift to a convergence of cultural and economic forces. Gen Z’s heightened health consciousness and aversion to the “brash” image of cocaine drive demand toward substances perceived as safer or more therapeutic, such as ketamine, which is marketed for its antidepressant properties. At the same time, the fear of fentanyl contamination—whether statistically rare or not—creates a risk‑averse environment. Supply‑side dynamics, including record‑high Colombian output and a jump in cocaine purity to 88%, make the drug more potent, raising the stakes for accidental overdose when combined with opioids. The result is a fragmented market where cocaine is no longer the sole “star” but one component of a broader, messier drug ecosystem.What Happens NextContinued decline in pure‑cocaine use, especially among younger cohorts, is likely as alternative psych‑delics gain cultural cachet.Regulators may increase monitoring of ketamine and novel stimulants, potentially introducing new scheduling or prescription‑only frameworks.Overdose prevention efforts will need to address mixed‑drug toxicity, emphasizing testing kits and education about fentanyl‑laced supplies.Drug‑trafficking organizations could pivot toward higher‑margin synthetics, reshaping the illicit market’s geography and profit structures.

Jasveen Sangha, a 42-year-old woman, has been sentenced to 15 years in prison for her role in supplying illegal drugs to Matthew Perry, the actor from the popular TV show Friends. Perry died from the 'acute effects of ketamine' in 2023.In a court appearance, Sangha expressed regret for her actions, stating, 'I take full responsibility for my actions. These were horrible choices that ultimately proved tragic.'Sangha pleaded guilty to five felony drug counts linked to Perry's death, including distributing ketamine resulting in death. Her defence lawyers had requested a sentence limited to time already served, but District Judge Sherilyn Garnett handed down a harsher sentence, citing Sangha's continued sale of ketamine after Perry's death as a lack of remorse.Perry had struggled with substance abuse and prescription painkillers, sharing his experiences in his memoir, Friends, Lovers, and the Big Terrible Thing. Federal officials reported that Perry became addicted to ketamine during infusions at a clinic, and when doctors declined to increase his dosage, he turned to alternative sources.Sangha, referred to as the 'Ketamine Queen', admitted to selling 51 vials of ketamine to a go-between, who then sold them to Perry through his personal assistant. Prosecutors stated that this led to Perry's death from ketamine overdose.